x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DMM-001113
| Status | Age | Sex |
|---|---|---|
|
|
|
| Product Overview | |
|---|---|
| Model Description | This Tbx21 knockout mouse model was generated by knocking out the exon 2 region of the Tbx21. |
| Strain Name | C57BL/6J-Tbx21em1 |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | Immune-related; type 1 innate lymphoid cells (ILC1) research; ILC1-deficient mice. These mice may be useful in studies of acute and chronic asthma and chronic intestinal inflammation. |
| Target Information | |
|---|---|
| Target Name | Tbx21 |
| Synonyms | Tbet T-bet Tblym TBT1 |
| Gene ID | 57765 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
